As of May 24
| +0.04 / +0.79%|
The 6 analysts offering 12-month price forecasts for Raptor Pharmaceutical Corp have a median target of 7.00, with a high estimate of 11.00 and a low estimate of 4.00. The median estimate represents a +37.25% increase from the last price of 5.10.
The current consensus among 7 polled investment analysts is to Buy stock in Raptor Pharmaceutical Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.